Lanterne Dx is a comprehensive clinical histopathology contract research organization (CRO) and is driven by the latest in technology, methods and an expert team of PhD scientists and MD pathologists. Lanterne Dx’s facility includes a newly renovated 4500 sf CLIA-certified and CAP compliant laboratory providing services in connection with human clinical trials and validations of related activities. We consistently add to our vast library of optimized antibodies and are supported by a highly trained scientific staff. We continue to grow these teams by adding new, qualified technicians, by providing additional training, quality oversight, a healthy culture and the newest equipment available.
Lanterne Dx’s capabilities include qualitative and quantitative immunohistochemical, immunofluorescent, in situ hybridization, and microscopic applications. We deliver pre- and post-intervention analysis of clinically derived materials for diagnostics and characterization of anti-tumor efficacy endpoints. As a valuable compliment to the IHC services, Lanterne Dx also offers the latest imaging technology with Aperio AT2 high-throughput slide scanners, fluorescent whole-slide scanners and the well-respected, and versatile Visiopharm image analysis software.
From routine and specialized histology support to optimized or custom protocols for your IHC, IF, and ISH needs (monoplex or multiplex), Lanterne Dx can provide you with the most critical data for your biomarker strategies.
Reach out to get the latest in pricing and services.